Medtronic plc (MDT) is set to announce its Q116 earnings before the markets open on Thursday, September 3. Analysts expect the software giant to report earnings per share of $1.01 and revenue of $7.05 billion. That would be $0.15 lower the $1.16 per share posted last quarter and $0.08 higher the $0.93 posted in the Q115. Revenue is projected to be $2.78 billion higher than the $4.27 billion posted in the same period a year earlier. Meanwhile, EarningsWhisper.com reports a whisper number of $1.03 per share.
As a quick reminder, MDT reported Q415 EPS of $1.16, $0.06 better than the Street’s consensus estimate of $1.10. Revs increased 58.70% year-over-year to $7.3 billion versus the $7.14 billion consensus.
On valuation measures, Medtronic PLC stock it’s trading at a forward P/E multiple of 14.78x, and at a multiple of 29.69x this year’s estimated earnings. The t-12-month revenue at Medtronic PLC is $20.13 billion. MDT ‘s ROE for the same period is 7.36%.
Shares of the $101.19 billion market cap company are up 13.29% year-over-year and 0.00% year-to-date.
Medtronic PLC, currently with a median Wall Street price target of $88.00 and a high target of $91.00, rose $2.02 to $71.55 in recent trading.
Update: Medtronic shares are up $0.09 to $71.64 in morning trading Thursday after the company reported its first quarter earnings results 2016.
The medical device maker posted earnings of $1.02 per share on revenues – including that generated by the recently acquired Covidien – of $7.27 billion. Analysts were expecting EPS of $1.01 on revenues of $7.05 billion.
For FY16, Dublin, Ireland-based Medtronic gave its bottom line range of $4.30 – $4.40 per share, against projections of $4.37 per share.